• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN LAP-BAND AP ADJUSTABLE GASTRIC BANDING SYSTEM (STANDARD); IMPLANT, INTRAGASTRIC FOR MORBID OBESITY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN LAP-BAND AP ADJUSTABLE GASTRIC BANDING SYSTEM (STANDARD); IMPLANT, INTRAGASTRIC FOR MORBID OBESITY Back to Search Results
Catalog Number B-2240
Device Problems Fluid/Blood Leak (1250); Device Slipped (1584)
Patient Problems Failure of Implant (1924); Not Applicable (3189)
Event Date 10/09/2011
Event Type  Injury  
Event Description
Physician reported recent lap-band port removal and replacement surgery due to a "leaking port.".
 
Manufacturer Narrative
Taper ii.The device has been received and is pending analysis.Following device analysis any additional information will be reported in a supplemental medwatch.Device labeling addresses the possible outcome of leakage as follows: "deflation of the band may occur due to leakage from the band, the port or the connector tubing.".
 
Manufacturer Narrative
Taper ii.Medwatch sent to fda on 11/10/2014.Visual examination of the returned device determined the access port tubing connector to be a taper ii.Device analysis of the access port and the taper tubing junction indicated a smooth opening consistent with wear and tear.Band tubing was broken with striations consistent with surgical end cut.Damaged port septum was missing material.Device labelling addresses the potential for smooth openings as follows "failure to create a stable, smooth path for the access port tubing, without sharp turns or bends, can result in tubing breaks and leakage in order to avoid incorrect placement, the port should be placed lateral to the trocar opening and a pocket must be created for the port so that it is placed far enough from the trocar path to avoid abrupt kinking of the tubing.The tubing path should point in the direction of the access port connector so that the tubing will form a straight line with a gentle arching transition into the abdomen." device labeling addresses the possible outcome of leakage as follows "when adjusting band volume take care to ensure the radiographic screen is perpendicular to the needle shaft (the needle will appear as a dot on the screen).This will facilitate adjustment of needle position as needed while moving through the tissue to the port"."when adjusting band volume once the septum is punctured, do not tilt or rock the needle as this may cause fluid leakage or damage to the septum.".
 
Manufacturer Narrative
Device labeling addresses the possible outcome of band slippage as follows.Band slippage is a surgical/physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.
 
Event Description
Healthcare professional reported an event of band slippage / gastric prolapse, treatment not reported.
 
Event Description
Healthcare professional updated the event of band slippage/gastric prolapse to include the following treatment; hospitalization and surgery which consisted of a lap-band®ap system surgical revision to re-position the lap-band®ap system (with preservation of same band).Healthcare professional reported an event of gastroesophageal reflux; a lap-band®ap system adjustment took place to treat the event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LAP-BAND AP ADJUSTABLE GASTRIC BANDING SYSTEM (STANDARD)
Type of Device
IMPLANT, INTRAGASTRIC FOR MORBID OBESITY
Manufacturer (Section D)
ALLERGAN
la aurora de heredia
CS 
Manufacturer (Section G)
COSTA RICA
900 pkwy global
park zona franca
Manufacturer Contact
laura leboeuf
1120 s capital of texas hwy
bulding 1, suite 300
austin, TX 78748
8555513123
MDR Report Key4515810
MDR Text Key18088287
Report Number2024601-2014-00560
Device Sequence Number1
Product Code LTI
UDI-Device Identifier10811955020183
UDI-Public(01)10811955020183
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P000008
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 08/27/2012
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/08/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/11/2012
Device Catalogue NumberB-2240
Device Lot Number1800147
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/29/2014
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/11/2015
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/01/2010
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age41 YR
Patient SexFemale
Patient Weight106 KG
-
-